Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunxia Su

Showing results (161-170 of 223) with videos related to

Pageof 23
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 8, 2018
Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?Fei Zhou, Likun Hou, Ting Ding, et al.
Chinese Medical Journal|August 21, 2024
Genomic correlates of the response to first-line PD-1 blockade plus chemotherapy in patients with advanced non-small-cell lung cancerTao Jiang, Jian Chen, Haowei Wang, et al.
Biological Procedures Online|May 7, 2024
PMS2 amplification contributes brain metastasis from lung cancerJianing Chen, Congli Hu, Hainan Yang, et al.
Experimental Hematology & Oncology|June 13, 2023
Mutational signatures of synchronous and metachronous brain metastases from lung adenocarcinomaJianing Chen, Hainan Yang, Chao Zhao, et al.
Therapeutic Advances in Medical Oncology|January 16, 2023
The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapyHaoran E, Junqi Wu, Yijiu Ren, et al.
Cell Biochemistry and Biophysics|June 19, 2012
Analysis of driver mutations in female non-smoker Asian patients with pulmonary adenocarcinomaShengxiang Ren, Peng Kuang, Limou Zheng, et al.
Frontiers in Oncology|June 13, 2022
The Treatment Status of Patients in NSCLC With RET Fusion Under the Prelude of Selective RET-TKI Application in China: A Multicenter Retrospective ResearchYan Meng, Yilin Yang, Yujia Fang, et al.
European Radiology|August 30, 2025
Pulmonary arterial blowout syndrome as a serious adverse event in patients with advanced lung cancer: a 12-year retrospective studyXu Ma, Xin Xu, Li Zhang, et al.
International Journal of Cancer|February 21, 2019
EGFR-targeted therapy alters the tumor microenvironment in EGFR-driven lung tumors: Implications for combination therapiesYijun Jia, Xuefei Li, Tao Jiang, et al.
Cancer|March 28, 2017
Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non-small cell lung cancerLimin Zhang, Tao Jiang, Xuefei Li, et al.
Pageof 23

Showing results (161-170 of 223) with videos related to

Sort By:
Pageof 23
Lung Cancer (Amsterdam, Netherlands)|February 8, 2018
Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?Fei Zhou, Likun Hou, Ting Ding, et al.
Chinese Medical Journal|August 21, 2024
Genomic correlates of the response to first-line PD-1 blockade plus chemotherapy in patients with advanced non-small-cell lung cancerTao Jiang, Jian Chen, Haowei Wang, et al.
Biological Procedures Online|May 7, 2024
PMS2 amplification contributes brain metastasis from lung cancerJianing Chen, Congli Hu, Hainan Yang, et al.
Experimental Hematology & Oncology|June 13, 2023
Mutational signatures of synchronous and metachronous brain metastases from lung adenocarcinomaJianing Chen, Hainan Yang, Chao Zhao, et al.
Therapeutic Advances in Medical Oncology|January 16, 2023
The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapyHaoran E, Junqi Wu, Yijiu Ren, et al.
Cell Biochemistry and Biophysics|June 19, 2012
Analysis of driver mutations in female non-smoker Asian patients with pulmonary adenocarcinomaShengxiang Ren, Peng Kuang, Limou Zheng, et al.
Frontiers in Oncology|June 13, 2022
The Treatment Status of Patients in NSCLC With RET Fusion Under the Prelude of Selective RET-TKI Application in China: A Multicenter Retrospective ResearchYan Meng, Yilin Yang, Yujia Fang, et al.
European Radiology|August 30, 2025
Pulmonary arterial blowout syndrome as a serious adverse event in patients with advanced lung cancer: a 12-year retrospective studyXu Ma, Xin Xu, Li Zhang, et al.
International Journal of Cancer|February 21, 2019
EGFR-targeted therapy alters the tumor microenvironment in EGFR-driven lung tumors: Implications for combination therapiesYijun Jia, Xuefei Li, Tao Jiang, et al.
Cancer|March 28, 2017
Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non-small cell lung cancerLimin Zhang, Tao Jiang, Xuefei Li, et al.
Pageof 23